Positrigo

Company overview

Positrigo is a Zurich-based medical device company founded in 2018 as an ETH Zurich spin-off. Led by co-founder and CEO Jannis Fischer, it develops compact positron emission tomography (PET) technology focused on functional brain imaging.

Its NeuroLF system combines a dedicated brain scanner, patient positioning and image-processing tools. The compact configuration is designed for clinical settings that want brain PET capability without installing a conventional whole-body PET scanner.

NeuroLF is available in the United States and European Union. Positrigo reports installations in outpatient neurology and hospital settings, including The Neuron Clinic in California and LMU Hospital in Germany. Its imaging applications include evaluation of dementia and other neurological disorders; the scanner does not itself establish an Alzheimer’s diagnosis independently of the clinical assessment.

^{[2][3][4][5][6][7]}

Products & regulatory status How does MedTechIndex get this information?

Summary

FDA cleared NeuroLF Basic, Pro and Advanced configurations and the NeuroLF Seat under K241751 on July 15, 2024. The clearance concerns the imaging system; it is not an authorization for an independent disease diagnosis or a disease-modifying treatment. ^[4][7][1]

Positrigo states that NeuroLF is available for sale in the United States and European Union. Its current installations and clinical research uses should be distinguished from the indications of particular PET radiopharmaceuticals. ^[4][7][1]

Regulatory snapshot How to read this snapshot

U.S. FDA

1+

510(k) clearances

—

De Novo grants

—

PMA approvals

—

Recall events

Latest recorded source review: 2026-11-05.

Scope: selected product families.

Commercial portfolio snapshot

Documented commercial product families.

Dedicated brain positron emission tomography system

NeuroLF brain PET system ↗

Compact PET scanner and patient-positioning system for functional imaging of the brain, with Basic, Pro and Advanced configurations included in the U.S. clearance. ^[7][1]

Commercial · U.S. 510(k)-cleared; EU availability